About the Company
We do not have any company description for Traws Pharma, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ONTX News
Traws Pharma Inc TRAW
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Traws Pharma Announces Equity Grants to Key Employees Following Recent Merger
Inc., Traws Pharma, Inc. (Nasdaq: TRAW) has awarded equity grants to five new employees as part of their employment ...
Traws Pharma Announces New Employee Inducement Grants
NEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has granted equity awards to new employees who joined Traws in ...
Traws Pharma, Inc.
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small ...
Traws Pharma Inc TRAW
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Traws Pharma, Inc. (TRAW)
Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.
Traws Pharma, Inc. Common Stock (TRAW)
© 2023 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission ...
Traws Pharma, Inc. (TRAW)
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
Traws Pharma, Inc. Common Stock (TRAW)
Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online. The net and percent change in the ...
Loading the latest forecasts...